BeiGene, Ltd. (688235) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

688235 BeiGene, Ltd.

Watchlist

162.01
-1.65-1.01%

Market Closed Dec 13 15:00 CST

224.03BMarket Cap-34.34P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Sector Update: Health Care Stocks Steady Premarket Friday
MT NewswiresDec 13 09:17 ET
Sector Update: Health Care
MT NewswiresDec 13 08:53 ET
CSPC Pharmaceutical Group Grants Exclusive License of Cancer Inhibitor to BeiGene Switzerland
MT NewswiresDec 13 04:48 ET
Express News | JPMorgan Chase & Co's Long Position in Shares of Beigene Increases to 10.94% on Dec 9 From 9.92% - HKEX
ReutersDec 13 04:22 ET
US MOVERS&SHAKERS Dec 09-Dec 13, 2024
Moomoo NewsDec 13 03:15 ET · Markets
Reported Earlier, BeiGene Secures Global Licensing Agreement For Novel MAT2A Inhibitor SYH2039 To Target MTAP-Deleted Solid Tumors
BenzingaDec 13 02:25 ET

Comments

EvaHuang

Nov 12 06:46

Seems the stock is forgotten by the market

$BEIGENE (06160.HK)$

AlanYeo

Feb 7 03:18

CIMB: Healthcare Overall – Overweight

The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
alphaedgeinvest...
$BEIGENE (06160.HK)$ $BeiGene (BGNE.US)$

AlanYeo

Jan 23 20:22

China Galaxy: BeiGene Ltd – Initiate coverage with an Add rating, Target Price HK$169.70

The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
China Galaxy: BeiGene Ltd – Initiate coverage with an Add rating, Target Price HK$169.70 - Alpha Edge Investing
$BEIGENE (06160.HK)$ $BeiGene (BGNE.US)$

Spinee

Jan 17 02:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...